Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lambrey

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Coeur Et Medecine Interne|January 1, 1978
[Beta-blockaders in the treatment of arterial hypertension. Part I. Pharmacologic, hemodynamic and metabolic aspects]M Andréjak, A Fournier, J M Hardin, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1978
Current status of the management of renal osteodystrophyA Fournier, J L Sebert, B Coevoet, et al.
Journal D'Urologie Et De Nephrologie|April 1, 1978
[Effect of hemofiltration on plasma levels of parathyroid hormone and calcitonin]J F De Fremont, A Fournier, J Gueris, et al.
Nephrologie|January 1, 1982
[Does 24,25 dihydroxycholecalciferol have a physiological and pathophysiological role?]J L Sebert, A Fournier, G Lambrey, et al.
Rheumatology (Oxford, England)|October 5, 2002
Sjögren syndrome: an unexpected disease occurring fourteen years after oligoarticular onset juvenile idiopathic arthritisK Bouayed, M-A Alyanakian, C Cordonnier, et al.
Coeur Et Medecine Interne|October 1, 1978
[Importance of diuretics in the treatment of arterial hypertension]M Andrejak, A Fournier, B Coevoet, et al.
La Nouvelle Presse Medicale|September 10, 1977
[Suppression of the antihypertensive effect of clonidine by the simultaneous intake of a tricyclic antidepressive agent. Practical problem in the treatment of a depressed hypertensive patient]M Andrejak, A Fournier, J M Hardin, et al.
Therapie|September 1, 1986
[Renal toxicity of nonsteroidal anti-inflammatory agents and clometacin]M Andrejak, R Makdassi, P Fievet, et al.
La Nouvelle Presse Medicale|November 5, 1977
[Renal osteodystrophy. I. Recent pathophysiological acquisitions (author's transl)]J L Sebert, A Fournier, J Gueris, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1990
Pharmacokinetics of oxiracetam in patients with renal impairment after a 800 mg single oral doseJ B Lecaillon, J P Dubois, H Coppens, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Coeur Et Medecine Interne|January 1, 1978
[Beta-blockaders in the treatment of arterial hypertension. Part I. Pharmacologic, hemodynamic and metabolic aspects]M Andréjak, A Fournier, J M Hardin, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1978
Current status of the management of renal osteodystrophyA Fournier, J L Sebert, B Coevoet, et al.
Journal D'Urologie Et De Nephrologie|April 1, 1978
[Effect of hemofiltration on plasma levels of parathyroid hormone and calcitonin]J F De Fremont, A Fournier, J Gueris, et al.
Nephrologie|January 1, 1982
[Does 24,25 dihydroxycholecalciferol have a physiological and pathophysiological role?]J L Sebert, A Fournier, G Lambrey, et al.
Rheumatology (Oxford, England)|October 5, 2002
Sjögren syndrome: an unexpected disease occurring fourteen years after oligoarticular onset juvenile idiopathic arthritisK Bouayed, M-A Alyanakian, C Cordonnier, et al.
Coeur Et Medecine Interne|October 1, 1978
[Importance of diuretics in the treatment of arterial hypertension]M Andrejak, A Fournier, B Coevoet, et al.
La Nouvelle Presse Medicale|September 10, 1977
[Suppression of the antihypertensive effect of clonidine by the simultaneous intake of a tricyclic antidepressive agent. Practical problem in the treatment of a depressed hypertensive patient]M Andrejak, A Fournier, J M Hardin, et al.
Therapie|September 1, 1986
[Renal toxicity of nonsteroidal anti-inflammatory agents and clometacin]M Andrejak, R Makdassi, P Fievet, et al.
La Nouvelle Presse Medicale|November 5, 1977
[Renal osteodystrophy. I. Recent pathophysiological acquisitions (author's transl)]J L Sebert, A Fournier, J Gueris, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1990
Pharmacokinetics of oxiracetam in patients with renal impairment after a 800 mg single oral doseJ B Lecaillon, J P Dubois, H Coppens, et al.
Pageof 4